CritiTech Particle Engineering Solutions (CT PES) is a rapidly-growing, multi-service, pharmaceutical Contract Development Manufacturing Organization (CDMO) and Contract Research Organization (CRO) with extensive experience and expertise in particle engineering, material characterization, analytical testing, early-stage drug development, and pre-clinical and clinical manufacturing. CritiTech Particle Engineering Solutions uses two primary technologies to help its customers engineer, formulate and manufacture their drugs – Spray Drying and Supercritical Precipitation. CritiTech Particle Engineering Solutions provides a suite of CDMO services, helping its customers develop new drugs and improved next generation particles from proof-of-concept through Phase III cGMP clinical production.
Looking for a particular CritiTech Particle Engineering Solutions employee's phone or email?
The CritiTech Particle Engineering Solutions annual revenue was $5 million in 2026.
Matthew McClorey is the President and CEO of CritiTech Particle Engineering Solutions.
21 people are employed at CritiTech Particle Engineering Solutions.
CritiTech Particle Engineering Solutions is based in Lawrence, Kansas.
The NAICS codes for CritiTech Particle Engineering Solutions are [3254, 32, 32541, 325].
The SIC codes for CritiTech Particle Engineering Solutions are [283, 28].